Drug	Gene	Variant	Genotype	Clinical_relevance	Category
Amisulpride	MC4R	rs489693	A/A	may have an increased likelihood of weight gain and hypertriglyceridemia when taking amisulpride	yellow
Citalopram	SLC6A4	LS allele	LS	may have decreased response	yellow
Citalopram	SLC6A4	LS allele	SS	may have decreased response and increased risk for side effects	red
Citalopram	FKBP5	rs4713916	G/G	may have a reduced response to antidepressants	yellow
Citalopram	HTR2A	rs7997012	G/G	may be less likely to have improvement in symptoms	yellow
Escitalopram	SLC6A4	LS allele	SS	may have a decreased response or decreased improvement based on HAMD score reduction	yellow
Fluoxetine	FKBP5	rs4713916	A/G	may have a slightly reduced response to antidepressants	yellow
Fluoxetine	FKBP5	rs4713916	G/G	may have a reduced response to antidepressants	yellow
Mirtazapine	FKBP5	rs4713916	A/G	may have a slightly reduced response to antidepressants	yellow
Mirtazapine	FKBP5	rs4713916	G/G	may have a reduced response to antidepressants	yellow
Paroxetine	HTR1A	rs6295	C/G	may have an reduced response at 4 weeks of treatment	yellow
Paroxetine	HTR1A	rs6295	C/C	may have an reduced response at 4 weeks of treatment	yellow
Paroxetine	FKBP5	rs4713916	A/G	may have a slightly reduced response to antidepressants	yellow
Paroxetine	FKBP5	rs4713916	G/G	may have a reduced response to antidepressants	yellow
Venlafaxine	FKBP5	rs4713916	A/G	may have a slightly reduced response to antidepressants	yellow
Venlafaxine	FKBP5	rs4713916	G/G	may have a reduced response to antidepressants	yellow
